Lesson one: How to design a good experiment

It’s clear science has a reproducibility problem. What’s less clear is how to address it. Recently, the U.S. National Institutes of Health awarded the Global Biological Standards Institute (GBSI) $2.34 million to train students in good experimental design (also covered by The Scientist). The first week begins June 2018 at Harvard Medical School. We spoke … Continue reading Lesson one: How to design a good experiment

ORI: Ex-grad student “falsified and/or fabricated” data in PNAS submission

A former graduate student falsified or fabricated data in a manuscript submitted to the Proceedings of the National Academy of Sciences, according to the Office of Research Integrity at the U.S. Department of Health and Human Services. In a finding released Dec. 8, ORI said that Matthew Endo, a former graduate student at the University … Continue reading ORI: Ex-grad student “falsified and/or fabricated” data in PNAS submission

Professor sues UC Davis over forced retirement following misconduct inquiry

Last year, a professor brought a suit against his former university after it forced him to retire. Now, he’s adding defamation to his list of allegations. In a lawsuit filed July 14, 2016, Ishwarlal “Kenny” Jialal, a cardiovascular researcher who worked at the University of California, Davis Medical Center from 2002 to 2016, alleges the … Continue reading Professor sues UC Davis over forced retirement following misconduct inquiry

University investigation finds misconduct by bone researcher with 23 retractions

As a bone researcher continues to accrue retractions, an investigation at his former university has found misconduct in more than a dozen papers. On Nov. 15, Japan’s Hirosaki University announced it had identified fabrication and authorship issues in 13 papers by Yoshihiro Sato, and plagiarism in another. Sato, a professor at Hirosaki University Medical School … Continue reading University investigation finds misconduct by bone researcher with 23 retractions

Weekend reads: Problems in studies of gender; when scholarship is a crime; a journal about Mark Zuckerberg photos

The week at Retraction Watch featured a call to make peer reviews public, lots of news about Cornell food researcher Brian Wansink, and a request by the U.S. NIH that the researchers it funds don’t publish in bad journals. Here’s what was happening elsewhere:

NIH to researchers: Don’t publish in bad journals, please

The U.S. National Institutes of Health has noticed something: More of the research it’s funding is ending up in questionable journals. Recently, the agency issued a statement highlighting some qualities of these journals — aggressively soliciting submissions, failing to provide clear information about pricing — and urging researchers to avoid them. The NIH’s goal: to … Continue reading NIH to researchers: Don’t publish in bad journals, please

New York psychiatry researcher charged with embezzlement, faces jail time

A researcher specializing in post-traumatic stress disorder is facing jail time for allegedly embezzling tens of thousands of dollars of federal grant money. Yesterday, the US Attorney’s Office for the Southern District of New York and the U.S. Department of Health and Human Services’s Office of Inspector General (OIG) announced criminal charges against Alexander Neumeister, … Continue reading New York psychiatry researcher charged with embezzlement, faces jail time

Editorial board of public health journal resigns in protest

The editorial board of the International Journal of Occupational and Environmental Health resigned today in protest over ongoing battles involving the new editor and its handling of recent withdrawals. We’ve covered the board’s gripes with the journal and publisher, which date back to the spring, and include appointing a new editor with industry ties without … Continue reading Editorial board of public health journal resigns in protest

Lancet retracts and replaces news story about controversial abortion drug

The Lancet has retracted a journalist-written piece about a controversial drug used off-label to induce abortions, and replaced it with a corrected version. In the retraction notice, the journal said it “removed the information that we believe to be inaccurate.” The article, first published Oct. 28, 2017, highlights Pfizer’s decision to withdraw the drug, misoprostol, … Continue reading Lancet retracts and replaces news story about controversial abortion drug

Weekend reads: Ethical issues could cost university millions in funding; Stolen bone raises questions; Ingelfinger rides again

The week at Retraction Watch featured a the story of how a nonexistent paper earned 400 ciations, a lawsuit filed against a journal for publishing criticism, and the retraction and replacement of a paper by a group of anti-vaccine advocates. Here’s what was happening elsewhere: